Trial intelligence / Profile preview

Nexplanon Insertion with Next Generation Applicator

NCT00620035Phase 3Completed

Sponsor
Organon & Co.
Start
Mar 2007
Primary completion
Oct 2010
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of etonogestrel in contraception, sponsored by Organon & Co.. Started Mar 2007; status: completed.

02

Drugs

etonogestrel
03

Conditions

contraception

Beyond the preview

Go deeper on NCT00620035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00620035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call